CGI reports second-quarter profit up from a year ago
The business and technology consulting firm says it earned $429.7 million or $1.89 per diluted share for the quarter ended March 31.
The result compared with a profit $426.9 million or $1.83 per diluted share in the same quarter last year.
Revenue for the quarter totalled $4.02 billion, up from $3.74 billion a year earlier.
On an adjusted basis, CGI says it earned $2.12 per diluted share in its latest quarter, up from an adjusted profit of $1.97 per diluted share a year earlier.
Bookings for the quarter totalled $4.48 billion, while the company's backlog stood at $30.99 billion at the end of the quarter.
This report by The Canadian Press was first published April 30, 2025.
Companies in this story: (TSX:GIB.A)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Knight Announces Normal Course Issuer Bid
MONTREAL, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD) ("Knight" or the "Company"), a pan-American (ex-US) specialty pharmaceutical company, announced today acceptance by the Toronto Stock Exchange (the "TSX") of the Company's Notice of Intention to Make a Normal Course Issuer Bid ("NCIB"). Pursuant to the NCIB, the Company proposes to purchase, from time to time over the next 12 months, if considered advisable, up to 3,000,000 common shares of the Company, being approximately 3% of its 99,653,265 common shares issued and outstanding as of August 8, 2025. Purchases may commence on August 22, 2025 and will conclude on the earlier of the date on which purchases under the bid have been completed and August 21, 2026. The Company may purchase up to a daily maximum of 15,823 common shares (being 25% of the average daily trading volume of 63,293 common shares, for the last six calendar months). The common shares may be purchased for cancellation through the facilities of the TSX or through alternative Canadian trading systems at times and in numbers to be determined by the Company. The Company had previously sought and obtained approval from the TSX to purchase up to 5,312,846 common shares under an NCIB and the Company has, in the twelve months preceding this announcement, purchased 2,019,906 common shares through the facilities of the TSX and alternative Canadian trading systems at a weighted average price per share of $5.48. Knight also entered into an automatic share purchase plan with a broker in order to facilitate purchases of its common shares under the NCIB. Under Knight's automatic share purchase plan, Knight's broker may repurchase common shares which it would ordinarily not be permitted to due to regulatory restrictions or self-imposed blackout periods. Purchases will be made by Knight's broker based upon the parameters prescribed by the TSX and applicable Canadian securities laws and the terms of the parties' written agreement. The automatic share purchase plan has been pre-cleared by the TSX and will be implemented effective as of August 22, 2025. The Company believes that the market price of Knight's common shares, from time to time, may not reflect the inherent value of the Company and purchases of common shares pursuant to the bid may represent an appropriate and desirable use of the Company's funds. The price that Knight will pay for Common Shares in open market transactions will be the market price at the time of purchase. About Knight Therapeutics Inc. Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing and commercializing pharmaceutical products for Canada and Latin America. Knight's Latin American subsidiaries operate under United Medical, Biotoscana Farma and Laboratorio LKM. Knight Therapeutics Inc.'s shares trade on TSX under the symbol GUD. For more information about Knight Therapeutics Inc., please visit the company's web site at or Forward-Looking Statement This document contains forward-looking statements for Knight Therapeutics Inc. and its subsidiaries. These forward-looking statements, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements. Knight Therapeutics Inc. considers the assumptions on which these forward-looking statements are based to be reasonable at the time they were prepared but cautions the reader that these assumptions regarding future events, many of which are beyond the control of Knight Therapeutics Inc. and its subsidiaries, may ultimately prove to be incorrect. Factors and risks which could cause actual results to differ materially from current expectations are discussed in Knight Therapeutics Inc.'s Annual Report and in Knight Therapeutics Inc.'s Annual Information Form for the year ended December 31, 2024, as filed on Knight Therapeutics Inc. disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information or future events, except as required by law. CONTACT INFORMATION: Investor Contact: Knight Therapeutics Inc. Samira Sakhia Arvind Utchanah President & Chief Executive Officer Chief Financial Officer T: 514.484.4483 T. +598.2626.2344 F: 514.481.4116 Email: IR@ Email: IR@ Website: Website: in to access your portfolio
Yahoo
an hour ago
- Yahoo
CGI and Kesko enter strategic partnership to accelerate digital transformation
Stock Market Symbols GIB.A (TSX) GIB (NYSE) CGI to leverage global retail expertise to deliver tangible outcomes for Kesko HELSINKI, Finland, Aug. 20, 2025 /PRNewswire/ - CGI (TSX: GIB.A) (NYSE: GIB), one of the largest independent IT and business consulting services firms in the world, and retail services company Kesko have signed an agreement for a strategic partnership to accelerate digital transformation. The partnership covers a wide range of IT services, including end-user services, capacity and cloud services, as well as integrations. In addition, CGI will support the K Group retail network in digital development initiatives. "K Group's goal is to be a forerunner in digital services within the retail sector. In the competitive bidding process, our aim was to find a partner with the best capability to support our business growth and development by leveraging the newest technologies efficiently. The development of automation and AI-based solutions plays a significant role in renewing our business and improving productivity. CGI's strong international expertise combined with local presence convinced us of the company's ability to support us in achieving our objectives," says Arto Hiltunen, CIO at Kesko. "The current trend in the IT sector is that forerunner companies like Kesko are now building strategic collaboration models in which partners participate closely in business development and growth as shared goals and risks. We thank Kesko for the trust in forming a genuine and deep partnership, where the achievement of strategic goals is guided by joint metrics and investments," says Leena-Mari Lähteenmaa, President, CGI Finland, Poland and Baltics. CGI helps retail, consumer and services organizations leverage AI and data-driven strategies to boost profitability by delivering friction-free omnichannel customer experiences, enhancing supply chain agility, streamlining store operations, advancing sustainable transformation, and optimizing IT investments. Read more: About CGIFounded in 1976, CGI is among the largest independent IT and business consulting services firms in the world. With 93,000 consultants and professionals across the globe, CGI delivers an end-to-end portfolio of capabilities, from strategic IT and business consulting to systems integration, managed IT and business process services and intellectual property solutions. CGI works with clients through a local relationship model complemented by a global delivery network that helps clients digitally transform their organizations and accelerate results. CGI Fiscal 2024 reported revenue is CA$14.68 billion and CGI shares are listed on the TSX (GIB.A) and the NYSE (GIB). Learn more at View original content: SOURCE CGI Inc.
Business Insider
5 hours ago
- Business Insider
Orla Mining (OLA) Receives a Rating Update from a Top Analyst
In a report released on August 18, Michael Siperco from RBC Capital maintained a Buy rating on Orla Mining, with a price target of C$18.00. The company's shares closed yesterday at C$13.11. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Siperco is a top 100 analyst with an average return of 26.1% and a 67.47% success rate. Siperco covers the Basic Materials sector, focusing on stocks such as Lundin Gold, Orla Mining, and Equinox Gold. In addition to RBC Capital, Orla Mining also received a Buy from TR | OpenAI – 4o's Orla Bullionna in a report issued on August 13. However, yesterday, TR | OpenAI – 4o reiterated a Hold rating on Orla Mining (TSX: OLA). Based on Orla Mining's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of C$92.76 million and a net profit of C$26.09 million. In comparison, last year the company earned a revenue of C$62.95 million and had a GAAP net loss of C$58.44 million Based on the recent corporate insider activity of 45 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of OLA in relation to earlier this year.
